Information about the Company
Established in 1849 and headquartered in New York, Pfizer is one of the world’s leading innovative biopharmaceutical companies. Pfizer applies science and its global resources to bring therapies to people that extend and significantly improve their lives. The company strives to set the standard for quality, safety, and value in the discovery, development, and manufacture of healthcare products, including innovative medicines and vaccines.
Pfizer’s purpose is to deliver breakthroughs that change patients’ lives. Its culture is defined under four core values—courage, excellence, equity, and joy—which encompass the company’s development.
Founded in 1962, Pfizer Taiwan is the first multi-national pharmaceutical company established in Taiwan. The organization upholds the spirit of continuous innovation and a patient-centered philosophy. Over the last 60 years, Pfizer Taiwan collaborates with government agencies, healthcare providers, medical associations, patient groups, local communities, etc. to provide access to effective, reliable, and affordable healthcare treatments.
Company Culture & Company Activities
Pfizer Taiwan focuses on diversity, inclusion, and innovation. The company creates friendly and caring work to enable colleagues to maximize their full potential and achieve their career aspirations, and at the same time, fulfill the company’s mission and values.
Pfizer Taiwan DEI Council aims to enhance colleagues’ sense of belonging and extend impact among the community to build a DEI society. The DEI Council is dedicated to holding diverse programs engaging colleagues, patients, and communities in order to advocate voices for Diversity, Equity, and Inclusion.
Pfizer Taiwan Talent development strategy is based on the company’s strategic goals and culture. Pfizer Taiwan provides diversified development channels, including job rotations, shortterm assignments, project participation, and job shadowing. Through individualized development programs, employees are able to facilitate personal career development.
Pfizer Taiwan believes that DEI is the foundation of innovation. The company is committed to fostering a workplace where everyone can be at their best and every voice can be heard.
Established in 1849 and headquartered in New York, Pfizer is one of the world’s leading innovative biopharmaceutical companies. Pfizer applies science and its global resources to bring therapies to people that extend and significantly improve their lives. The company strives to set the standard for quality, safety, and value in the discovery, development, and manufacture of healthcare products, including innovative medicines and vaccines.
Pfizer’s purpose is to deliver breakthroughs that change patients’ lives. Its culture is defined under four core values—courage, excellence, equity, and joy—which encompass the company’s development.
Founded in 1962, Pfizer Taiwan is the first multi-national pharmaceutical company established in Taiwan. The organization upholds the spirit of continuous innovation and a patient-centered philosophy. Over the last 60 years, Pfizer Taiwan collaborates with government agencies, healthcare providers, medical associations, patient groups, local communities, etc. to provide access to effective, reliable, and affordable healthcare treatments.
Company Culture & Company Activities
Pfizer Taiwan focuses on diversity, inclusion, and innovation. The company creates friendly and caring work to enable colleagues to maximize their full potential and achieve their career aspirations, and at the same time, fulfill the company’s mission and values.
Pfizer Taiwan DEI Council aims to enhance colleagues’ sense of belonging and extend impact among the community to build a DEI society. The DEI Council is dedicated to holding diverse programs engaging colleagues, patients, and communities in order to advocate voices for Diversity, Equity, and Inclusion.
Pfizer Taiwan Talent development strategy is based on the company’s strategic goals and culture. Pfizer Taiwan provides diversified development channels, including job rotations, shortterm assignments, project participation, and job shadowing. Through individualized development programs, employees are able to facilitate personal career development.
Pfizer Taiwan believes that DEI is the foundation of innovation. The company is committed to fostering a workplace where everyone can be at their best and every voice can be heard.
Breakthroughs that change patients’ lives.
Achievements & Impact
Pfizer Taiwan is aiming to bring more than 25 innovations and breakthroughs to Taiwan by 2025. In 2021-22, 13 new drugs, vaccines, and indications were launched with reimbursement. The revenue in 2022 will reach USD280 million with a 6% growth YOY which implies more people with Rare Diseases, Infectious Diseases, Cardiovascular Disorders, and Cancer are treated by Pfizer Taiwan’s breakthroughs. In addition, Pfizer Taiwan was proud of introducing more than 1 million doses of oral treatment for COVID-19 in 2022 which helped Taiwan to address the outbreak successfully. All of these are demonstrating its Purpose: A breakthrough that changes patients’ life.
Future Direction
Pfizer Taiwan is striving for its “25 by 2025” aspiration to accelerate bringing new innovations to Taiwan. There will be 12 more launches and license approvals in 2023 which will pave the way to its goal. Pfizer Taiwan continuously executes around 50 clinical studies in Taiwan to bridge Taiwan’s leading experts with international leaders. Pfizer Taiwan also dedicates itself to leading the conversation and shaping the environment for these innovations including three MOU for Gene Therapy and two MOU for research and education with key medical centers by 2023. Pfizer Taiwan is committed to keeping investments and building strong partnerships with stakeholders in Taiwan for the next 60 years.
Pfizer Taiwan is aiming to bring more than 25 innovations and breakthroughs to Taiwan by 2025. In 2021-22, 13 new drugs, vaccines, and indications were launched with reimbursement. The revenue in 2022 will reach USD280 million with a 6% growth YOY which implies more people with Rare Diseases, Infectious Diseases, Cardiovascular Disorders, and Cancer are treated by Pfizer Taiwan’s breakthroughs. In addition, Pfizer Taiwan was proud of introducing more than 1 million doses of oral treatment for COVID-19 in 2022 which helped Taiwan to address the outbreak successfully. All of these are demonstrating its Purpose: A breakthrough that changes patients’ life.
Future Direction
Pfizer Taiwan is striving for its “25 by 2025” aspiration to accelerate bringing new innovations to Taiwan. There will be 12 more launches and license approvals in 2023 which will pave the way to its goal. Pfizer Taiwan continuously executes around 50 clinical studies in Taiwan to bridge Taiwan’s leading experts with international leaders. Pfizer Taiwan also dedicates itself to leading the conversation and shaping the environment for these innovations including three MOU for Gene Therapy and two MOU for research and education with key medical centers by 2023. Pfizer Taiwan is committed to keeping investments and building strong partnerships with stakeholders in Taiwan for the next 60 years.
CORPORATE EXCELLENCE CATEGORY
Pfizer Taiwan
Information about the Company
Established in 1849 and headquartered in New York, Pfizer is one of the world’s leading innovative biopharmaceutical companies. Pfizer applies science and its global resources to bring therapies to people that extend and significantly improve their lives. The company strives to set the standard for quality, safety, and value in the discovery, development, and manufacture of healthcare products, including innovative medicines and vaccines.
Pfizer’s purpose is to deliver breakthroughs that change patients’ lives. Its culture is defined under four core values—courage, excellence, equity, and joy—which encompass the company’s development.
Founded in 1962, Pfizer Taiwan is the first multi-national pharmaceutical company established in Taiwan. The organization upholds the spirit of continuous innovation and a patient-centered philosophy. Over the last 60 years, Pfizer Taiwan collaborates with government agencies, healthcare providers, medical associations, patient groups, local communities, etc. to provide access to effective, reliable, and affordable healthcare treatments.
Company Culture & Company Activities
Pfizer Taiwan focuses on diversity, inclusion, and innovation. The company creates friendly and caring work to enable colleagues to maximize their full potential and achieve their career aspirations, and at the same time, fulfill the company’s mission and values.
Pfizer Taiwan DEI Council aims to enhance colleagues’ sense of belonging and extend impact among the community to build a DEI society. The DEI Council is dedicated to holding diverse programs engaging colleagues, patients, and communities in order to advocate voices for Diversity, Equity, and Inclusion.
Pfizer Taiwan Talent development strategy is based on the company’s strategic goals and culture. Pfizer Taiwan provides diversified development channels, including job rotations, shortterm assignments, project participation, and job shadowing. Through individualized development programs, employees are able to facilitate personal career development.
Pfizer Taiwan believes that DEI is the foundation of innovation. The company is committed to fostering a workplace where everyone can be at their best and every voice can be heard.
Established in 1849 and headquartered in New York, Pfizer is one of the world’s leading innovative biopharmaceutical companies. Pfizer applies science and its global resources to bring therapies to people that extend and significantly improve their lives. The company strives to set the standard for quality, safety, and value in the discovery, development, and manufacture of healthcare products, including innovative medicines and vaccines.
Pfizer’s purpose is to deliver breakthroughs that change patients’ lives. Its culture is defined under four core values—courage, excellence, equity, and joy—which encompass the company’s development.
Founded in 1962, Pfizer Taiwan is the first multi-national pharmaceutical company established in Taiwan. The organization upholds the spirit of continuous innovation and a patient-centered philosophy. Over the last 60 years, Pfizer Taiwan collaborates with government agencies, healthcare providers, medical associations, patient groups, local communities, etc. to provide access to effective, reliable, and affordable healthcare treatments.
Company Culture & Company Activities
Pfizer Taiwan focuses on diversity, inclusion, and innovation. The company creates friendly and caring work to enable colleagues to maximize their full potential and achieve their career aspirations, and at the same time, fulfill the company’s mission and values.
Pfizer Taiwan DEI Council aims to enhance colleagues’ sense of belonging and extend impact among the community to build a DEI society. The DEI Council is dedicated to holding diverse programs engaging colleagues, patients, and communities in order to advocate voices for Diversity, Equity, and Inclusion.
Pfizer Taiwan Talent development strategy is based on the company’s strategic goals and culture. Pfizer Taiwan provides diversified development channels, including job rotations, shortterm assignments, project participation, and job shadowing. Through individualized development programs, employees are able to facilitate personal career development.
Pfizer Taiwan believes that DEI is the foundation of innovation. The company is committed to fostering a workplace where everyone can be at their best and every voice can be heard.
Breakthroughs that change patients’ lives.
Achievements & Impact
Pfizer Taiwan is aiming to bring more than 25 innovations and breakthroughs to Taiwan by 2025. In 2021-22, 13 new drugs, vaccines, and indications were launched with reimbursement. The revenue in 2022 will reach USD280 million with a 6% growth YOY which implies more people with Rare Diseases, Infectious Diseases, Cardiovascular Disorders, and Cancer are treated by Pfizer Taiwan’s breakthroughs. In addition, Pfizer Taiwan was proud of introducing more than 1 million doses of oral treatment for COVID-19 in 2022 which helped Taiwan to address the outbreak successfully. All of these are demonstrating its Purpose: A breakthrough that changes patients’ life.
Future Direction
Pfizer Taiwan is striving for its “25 by 2025” aspiration to accelerate bringing new innovations to Taiwan. There will be 12 more launches and license approvals in 2023 which will pave the way to its goal. Pfizer Taiwan continuously executes around 50 clinical studies in Taiwan to bridge Taiwan’s leading experts with international leaders. Pfizer Taiwan also dedicates itself to leading the conversation and shaping the environment for these innovations including three MOU for Gene Therapy and two MOU for research and education with key medical centers by 2023. Pfizer Taiwan is committed to keeping investments and building strong partnerships with stakeholders in Taiwan for the next 60 years.
Pfizer Taiwan is aiming to bring more than 25 innovations and breakthroughs to Taiwan by 2025. In 2021-22, 13 new drugs, vaccines, and indications were launched with reimbursement. The revenue in 2022 will reach USD280 million with a 6% growth YOY which implies more people with Rare Diseases, Infectious Diseases, Cardiovascular Disorders, and Cancer are treated by Pfizer Taiwan’s breakthroughs. In addition, Pfizer Taiwan was proud of introducing more than 1 million doses of oral treatment for COVID-19 in 2022 which helped Taiwan to address the outbreak successfully. All of these are demonstrating its Purpose: A breakthrough that changes patients’ life.
Future Direction
Pfizer Taiwan is striving for its “25 by 2025” aspiration to accelerate bringing new innovations to Taiwan. There will be 12 more launches and license approvals in 2023 which will pave the way to its goal. Pfizer Taiwan continuously executes around 50 clinical studies in Taiwan to bridge Taiwan’s leading experts with international leaders. Pfizer Taiwan also dedicates itself to leading the conversation and shaping the environment for these innovations including three MOU for Gene Therapy and two MOU for research and education with key medical centers by 2023. Pfizer Taiwan is committed to keeping investments and building strong partnerships with stakeholders in Taiwan for the next 60 years.